Latest News and Press Releases
Want to stay updated on the latest news?
-
Results Driven by 60% Growth in Revenue Company Reiterates 2016 Guidance Company to Host Conference Call Today at 8:30 a.m. EDT ROCKVILLE, Md., May 04, 2016 (GLOBE NEWSWIRE) -- Sucampo...
-
ROCKVILLE, Md., May 03, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
-
ROCKVILLE, Md., April 20, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter...
-
ROCKVILLE, Md., April 19, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced top-line data from a Phase 2a study of...
-
ROCKVILLE, Md., March 09, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
-
Results Driven by Continued AMITIZA Growth and R-TECH UENO Acquisition Company Reiterates 2016 Guidance Company to Host Conference Call Today at 8:30 a.m. EST ROCKVILLE, Md., March 08, 2016 ...
-
ROCKVILLE, Md., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter...
-
ROCKVILLE, Md., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
-
Addresses Significant Patient Need Aligned With GI Expertise, Strategic Focus Phase 3 Study Expected to be Complete in 2018 ROCKVILLE, Md., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Sucampo...
-
ROCKVILLE, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today provided additional detail regarding its...